Affinage

RD3

Protein RD3 · UniProt Q7Z3Z2

Length
195 aa
Mass
22.7 kDa
Annotated
2026-04-28
37 papers in source corpus 10 papers cited in narrative 10 extracted findings

Mechanistic narrative

Synthesis pass · prose summary of the discoveries below

RD3 is a photoreceptor-specific regulatory protein that controls retinal guanylyl cyclase (RetGC) activity and trafficking, thereby safeguarding photoreceptor viability. RD3 physically binds GC1 and GC2 through two surface-exposed clusters (near Leu63 and Arg101) on an elongated four-helix bundle, functioning as a potent noncompetitive inhibitor that suppresses both basal and GCAP-stimulated RetGC catalytic activity at submicromolar concentrations (PMID:21928830, PMID:32493772, PMID:30559291). RD3 also promotes ER export and outer-segment trafficking of GC1/GC2; in rd3-null photoreceptors, guanylyl cyclases are retained in the inner segment ER where unchecked GCAP-dependent activation at low Ca²⁺ triggers ER stress, mitochondrial swelling, and photoreceptor degeneration—a mechanism confirmed by genetic epistasis showing that GCAPs ablation substantially rescues rd3 photoreceptors (PMID:21078983, PMID:31346032, PMID:31980596). Loss-of-function mutations in RD3 cause Leber congenital amaurosis type 12 (LCA12), and AAV-mediated RD3 gene replacement restores GC trafficking, photoreceptor survival, and visual function in the rd3 mouse (PMID:23740938).

Mechanistic history

Synthesis pass · year-by-year structured walk · 10 steps
  1. 2006 Medium

    Initial characterization showed RD3 localizes to subnuclear regions near PML bodies in heterologous cells and that the LCA12-associated truncation destabilizes the protein, establishing that disease-linked mutations disrupt RD3 stability.

    Evidence Transient transfection of COS-1 cells with RD3-fusion constructs, immunofluorescence

    PMID:17186464

    Open questions at the time
    • Overexpression in non-photoreceptor cells; subnuclear localization not confirmed in photoreceptors
    • No functional assay linking localization to mechanism
    • No interaction partner identified
  2. 2010 High

    Identification of GC1 and GC2 as direct binding partners of RD3 in photoreceptors resolved the molecular target, and demonstration that rd3-null retinas lack outer-segment GC1/GC2 established RD3 as essential for cyclase trafficking from the ER.

    Evidence Reciprocal co-immunoprecipitation from retinal and HEK293 cell extracts, immunofluorescence of rd3 mouse retinas, ER-to-vesicle trafficking assays

    PMID:21078983

    Open questions at the time
    • Mechanism by which RD3 promotes ER export not defined
    • Whether RD3 also regulates GC catalytic activity unknown at this point
  3. 2011 High

    Reconstitution of RD3 with purified RetGC revealed that RD3 is a high-affinity allosteric inhibitor of cyclase activity, acting noncompetitively and Ca²⁺-independently, and that LCA12 mutations abolish this inhibition—establishing a dual trafficking/inhibitory role.

    Evidence In vitro RetGC activity assays with purified components, site-directed mutagenesis of disease-associated RD3 variants

    PMID:21928830

    Open questions at the time
    • Binding interface on RD3 not mapped
    • Relative contribution of trafficking vs. inhibitory function to photoreceptor survival unclear
  4. 2013 High

    AAV-mediated RD3 gene replacement in rd3 mice restored GC1/GC2 outer-segment localization, photoreceptor survival, and visual function, providing in vivo proof that RD3 is both necessary and sufficient for photoreceptor rescue.

    Evidence Subretinal AAV8-Rd3 injection, electroretinography, immunofluorescence, photoreceptor cell counting over 7 months

    PMID:23740938

    Open questions at the time
    • Long-term durability beyond 7 months not assessed
    • Relative rescue of rods vs. cones not fully characterized
  5. 2016 High

    Systematic mutagenesis of conserved RD3 regions mapped the primary RetGC-binding interface to residues Lys87–Leu122, with Cys93 critical for co-localization, identifying the structural determinants of cyclase regulation.

    Evidence Alanine/scramble mutagenesis across 22 conserved regions, in vitro RetGC inhibition assays, HEK293 co-localization

    PMID:27471269

    Open questions at the time
    • Three-dimensional structure of RD3 not yet available
    • Whether binding interface is also the trafficking-competence determinant unknown
  6. 2018 High

    The NMR solution structure of RD3 revealed an elongated four-helix bundle and showed that RetGC-binding residues cluster on a contiguous surface between helices 2–4, providing the first structural framework for understanding cyclase regulation.

    Evidence NMR structure determination of RD3 residues 18–160, mutagenesis-validated binding assays

    PMID:30559291

    Open questions at the time
    • No co-structure of RD3–RetGC complex
    • Structural basis for trafficking function vs. inhibitory function not resolved
  7. 2019 High

    Genetic epistasis demonstrated that the proximate cause of photoreceptor death in rd3 mice is unchecked GCAP-dependent RetGC activation at low Ca²⁺: ablation of GCAPs rescued ~70% of photoreceptors, and transgenic RD3-GFP in inner segments competed with GCAPs for RetGC binding, restoring visual function.

    Evidence rd3/rd3 × GCAPs−/− double mutant mice, transgenic RD3-GFP expression, ERG, in vitro RetGC assay

    PMID:31346032

    Open questions at the time
    • Whether RD3 and GCAPs bind overlapping or distinct sites on RetGC not determined
    • Stoichiometry of the RD3–RetGC complex unknown
  8. 2020 High

    Comprehensive surface-residue mutagenesis (133 positions) resolved two discrete surface-exposed clusters on RD3 (near Leu63 and Arg101) required for high-affinity RetGC1 inhibition, while showing the C-terminal 49 residues are dispensable—refining the minimal binding determinants.

    Evidence Systematic single-substitution mutagenesis, in vitro reconstitution with GCAP1-activated RetGC1, HEK293 co-localization

    PMID:32493772

    Open questions at the time
    • Whether the two clusters engage one or two distinct sites on RetGC unknown
    • No direct trafficking assay performed for surface mutants
  9. 2020 High

    Characterization of ER stress and mitochondrial swelling as early pathological events in rd3 retinas—rescued by GCAPs ablation—established the cell-biological mechanism linking unregulated cGMP synthesis to photoreceptor apoptosis.

    Evidence ER stress markers, electron microscopy, genetic epistasis (rd3 × GCAPs−/−), photoreceptor counting

    PMID:31980596

    Open questions at the time
    • Whether ER stress is caused directly by cGMP overproduction or indirectly by mislocalized GC remains unclear
    • Downstream apoptotic pathway not fully delineated
  10. 2026 High

    Discovery that GCAP1 directly binds RD3 in a Ca²⁺-dependent manner (KD ~1.6 µM for Ca²⁺-bound GCAP1) revealed a dual inhibition mechanism whereby RD3 suppresses RetGC both directly and via GCAP1 sequestration, and the IRD-associated E111V GCAP1 mutation abolishes this interaction.

    Evidence NMR spectroscopy, surface plasmon resonance, enzymatic activity assays, immunohistochemistry of mouse retinas

    PMID:41819313

    Open questions at the time
    • Whether a ternary RD3–GCAP1–GC1 complex forms in vivo is unresolved
    • Physiological relevance of Ca²⁺-dependent vs. Ca²⁺-independent RD3 interactions not tested in photoreceptors

Open questions

Synthesis pass · forward-looking unresolved questions
  • Key unresolved questions include the atomic structure of RD3 in complex with RetGC and/or GCAP1, the mechanism by which RD3 promotes ER export (whether via a specific cargo receptor or direct coat interaction), and whether the inhibitory and trafficking functions of RD3 are mechanistically separable.
  • No co-crystal or cryo-EM structure of RD3–RetGC complex
  • ER export mechanism (coat interaction, cargo receptor) completely uncharacterized
  • Separation-of-function mutants distinguishing trafficking from inhibition not yet identified

Mechanism profile

Synthesis pass · controlled-vocabulary classification · explore literature graph →
Molecular activity
GO:0098772 molecular function regulator activity 5
Localization
GO:0005783 endoplasmic reticulum 3 GO:0005829 cytosol 2
Pathway
R-HSA-9609507 Protein localization 2 R-HSA-9709957 Sensory Perception 2
Partners
GUCA1AGUCY2DGUCY2F

Evidence

Reading pass · 10 per-paper findings extracted from the source corpus
Year Finding Method Journal Conf PMIDs
2006 RD3 protein exhibits subnuclear localization adjacent to promyelocytic leukemia (PML) bodies in transiently transfected COS-1 cells; the truncated mutant RD3 protein is rapidly degraded in COS-1 cells. Transient transfection of COS-1 cells with RD3-fusion protein, immunofluorescence microscopy American journal of human genetics Medium 17186464
2010 RD3 colocalizes and physically interacts with guanylate cyclases GC1 and GC2 in rod and cone photoreceptor cells; in rd3 mice deficient in RD3, GC1 and GC2 are undetectable in photoreceptors; cell expression studies show RD3 mediates export of GC1 from the endoplasmic reticulum to endosomal vesicles, and the C-terminus of GC1 is required for RD3 binding. Co-immunoprecipitation from retinal cell extracts and HEK293 cells, immunofluorescence microscopy of rd3 mouse retinas, cell expression trafficking assays Proceedings of the National Academy of Sciences of the United States of America High 21078983
2011 RD3 is a high-affinity allosteric inhibitor of retinal membrane guanylyl cyclase (RetGC), suppressing basal RetGC activity in a noncompetitive manner at submicromolar concentrations and inhibiting GCAP-stimulated RetGC activity at low Ca2+; disease-associated mutations (including the LCA12 C-terminal truncation and G57V) reduce RD3's affinity for RetGC1 or abolish inhibitory activity; inhibition of RetGC by RD3 may function to block cyclase activity during its maturation/trafficking. In vitro RetGC activity assays with purified or expressed RD3 and RetGC1/GCAP, site-directed mutagenesis of disease-associated RD3 variants, HEK293 cell expression Biochemistry High 21928830
2013 AAV8-mediated delivery of Rd3 cDNA to rd3 mouse photoreceptors restores GC1 and GC2 translocation from the ER to rod and cone outer segments, rescues photoreceptor survival for at least 7 months, and restores rod and cone visual function as measured by ERG; this confirms RD3's essential role in GC exit from the ER and trafficking to outer segments. Subretinal AAV injection, immunofluorescence microscopy, electroretinography, photoreceptor cell counting Human molecular genetics High 23740938
2016 The main RetGC-binding interface on RD3 required for negative regulation of the cyclase maps to the Lys87–Leu122 central region; substitutions in four conserved regions—(87)KIHP(90), (93)CGPAI(97), (99)RFRQ(102), and (119)RSVL(122)—reduced apparent RD3 affinity for the cyclase 180–700-fold; mutations in (93)CGPAI(97) (especially Cys93) most drastically disrupted RD3 co-localization with RetGC1 in HEK293 cells. Alanine/sequence-scramble mutagenesis of conserved RD3 regions, in vitro RetGC inhibition assays, co-localization in co-transfected HEK293 cells The Journal of biological chemistry High 27471269
2018 NMR solution structure of human RD3 (residues 18–160) reveals an elongated four-helix bundle (~70 Å × 30 Å) with a long unstructured loop between helices 1 and 2; residues previously implicated in RetGC binding map to a localized contiguous area involving the loop between helices 2 and 3 and adjacent parts of helices 3 and 4; mutagenesis of hydrophobic core residues (Trp85, Phe29, Glu32, Cys93) validated the structure and its relevance to RetGC1 binding affinity. NMR solution structure determination, site-directed mutagenesis, in vitro RetGC binding/inhibition assays The Journal of biological chemistry High 30559291
2019 RD3 protects photoreceptors from degeneration by competing with GCAPs for RetGC binding; in rd3/rd3 retinas, residual RetGC is stimulated by GCAPs at low Ca2+; ablation of GCAPs in rd3/rd3 mice rescued ~70% of photoreceptors past 6 months (vs. <5% in rd3/rd3 alone); RD3-GFP expressed in rd3/rd3 rods inhibited GCAP-dependent RetGC activation in vitro and in vivo, increased RetGC levels, restored photoresponses, and rescued rods; RD3-GFP localized predominantly to inner segments where it competes with GCAPs to prevent premature cyclase activation. Genetic epistasis (rd3/rd3 × GCAPs−/− double mutant), transgenic RD3-GFP expression, ERG, immunofluorescence, in vitro RetGC activity assay The Journal of biological chemistry High 31346032
2020 Two distinct surface-exposed clusters on RD3—one adjacent to Leu63 in the loop connecting helices 1 and 2, and one surrounding Arg101 on helix 3—are required for high-affinity inhibitory binding to RetGC1; single substitutions in these clusters reduced IC50 up to 245-fold; deletion of 49 C-terminal residues did not affect apparent affinity; inactivation of both clusters completely disabled RD3 binding to RetGC1 in living HEK293 cells. Systematic single substitution/deletion mutagenesis of 133 surface-exposed residues, in vitro reconstitution with purified GCAP1-activated human RetGC1, co-localization in HEK293 cells The Journal of biological chemistry High 32493772
2020 In rd3 mice, GCAPs are retained at the inner segment in their Ca2+-free guanylate cyclase-activator state, inducing endoplasmic reticulum stress and mitochondrial swelling that precede photoreceptor cell death; GCAPs ablation substantially delays retinal degeneration in rd3 mice (photoreceptor number halved at ~8 months vs. 6 weeks in rd3 alone); ER stress and mitochondrial swelling are early hallmarks rescued by GCAPs ablation. Genetic epistasis (rd3/rd3 × GCAPs−/− double mutant), immunofluorescence, ER stress markers, electron microscopy, cell counting Cell death & disease High 31980596
2026 GCAP1 interacts directly with RD3 in a strongly Ca2+-dependent manner (Ca2+-bound GCAP1 KD ~1.6 μM; Mg2+-bound GCAP1 binds much more weakly); the IRD-associated E111V GCAP1 mutation completely abolishes RD3 binding; GCAP1 residues mediating RD3 binding overlap with those involved in GCAP1 dimerization and GC1 interaction; RD3 inhibits GC1 via dual mechanisms—direct binding to GC1 and GCAP1-mediated inhibition; GCAP1, RD3, and GC1 co-localize at photoreceptor inner segments and synaptic terminals. NMR spectroscopy, surface plasmon resonance, AlphaFold3 modeling, enzymatic activity assays, immunohistochemistry International journal of biological macromolecules High 41819313

Source papers

Stage 0 corpus · 37 papers · ranked by NIH iCite citations
Year Title Journal Citations PMID
2006 Premature truncation of a novel protein, RD3, exhibiting subnuclear localization is associated with retinal degeneration. American journal of human genetics 99 17186464
2010 RD3, the protein associated with Leber congenital amaurosis type 12, is required for guanylate cyclase trafficking in photoreceptor cells. Proceedings of the National Academy of Sciences of the United States of America 85 21078983
1976 The fine structure of neoplastic invasion: invasion of liver, skeletal muscle and lymphatic vessels by the Rd/3 tumour. The Journal of pathology 72 130474
1993 New mouse primary retinal degeneration (rd-3). Genomics 61 8486383
2013 RD3 gene delivery restores guanylate cyclase localization and rescues photoreceptors in the Rd3 mouse model of Leber congenital amaurosis 12. Human molecular genetics 48 23740938
2009 Canine RD3 mutation establishes rod-cone dysplasia type 2 (rcd2) as ortholog of human and murine rd3. Mammalian genome : official journal of the International Mammalian Genome Society 46 19130129
2011 Retinal degeneration 3 (RD3) protein inhibits catalytic activity of retinal membrane guanylyl cyclase (RetGC) and its stimulation by activating proteins. Biochemistry 42 21928830
2016 Functional Study and Mapping Sites for Interaction with the Target Enzyme in Retinal Degeneration 3 (RD3) Protein. The Journal of biological chemistry 31 27471269
2014 Insights into the role of RD3 in guanylate cyclase trafficking, photoreceptor degeneration, and Leber congenital amaurosis. Frontiers in molecular neuroscience 26 24904271
2008 Genetic modifiers of retinal degeneration in the rd3 mouse. Investigative ophthalmology & visual science 22 18344445
2012 Mutations in RD3 are associated with an extremely rare and severe form of early onset retinal dystrophy. Investigative ophthalmology & visual science 21 22531706
2010 Photoinactivation of F. nucleatum and P. gingivalis using the ruthenium-based RD3 sensitizer and a conventional halogen lamp. Archives of oral biology 21 21036348
2005 Morphological characterization of the retinal degeneration in three strains of mice carrying the rd-3 mutation. Visual neuroscience 19 16469183
1999 Efficacy of RD3-0028 aerosol treatment against respiratory syncytial virus infection in immunosuppressed mice. Antimicrobial agents and chemotherapy 18 10103176
2021 Regulation of retinal membrane guanylyl cyclase (RetGC) by negative calcium feedback and RD3 protein. Pflugers Archiv : European journal of physiology 17 33537894
2018 Retinal degeneration 3 (RD3) protein, a retinal guanylyl cyclase regulator, forms a monomeric and elongated four-helix bundle. The Journal of biological chemistry 16 30559291
2015 RD3 loss dictates high-risk aggressive neuroblastoma and poor clinical outcomes. Oncotarget 16 26375249
2013 Union makes strength: a worldwide collaborative genetic and clinical study to provide a comprehensive survey of RD3 mutations and delineate the associated phenotype. PloS one 14 23308101
2001 Mechanism of selective inhibition of respiratory syncytial virus by a benzodithiin compound (RD3-0028). Microbiology and immunology 13 11529559
2019 Retinal guanylyl cyclase activation by calcium sensor proteins mediates photoreceptor degeneration in an rd3 mouse model of congenital human blindness. The Journal of biological chemistry 11 31346032
2003 Identification and characterization of C1orf36, a transcript highly expressed in photoreceptor cells, and mutation analysis in retinitis pigmentosa. Biochemical and biophysical research communications 11 12914764
2020 GCAP neuronal calcium sensor proteins mediate photoreceptor cell death in the rd3 mouse model of LCA12 congenital blindness by involving endoplasmic reticulum stress. Cell death & disease 10 31980596
1999 Genetic and physical maps of the mouse rd3 locus; exclusion of the ortholog of USH2A. Mammalian genome : official journal of the International Mammalian Genome Society 10 10384036
2019 De novo regulation of RD3 synthesis in residual neuroblastoma cells after intensive multi-modal clinical therapy harmonizes disease evolution. Scientific reports 9 31409909
2017 Retinal Degeneration Protein 3 (RD3) in normal human tissues: Novel insights. Scientific reports 9 29030614
1999 Determination of the solution structure of the N-domain plus linker of Antarctic eel pout antifreeze protein RD3. Journal of biochemistry 9 10423534
2020 Two clusters of surface-exposed amino acid residues enable high-affinity binding of retinal degeneration-3 (RD3) protein to retinal guanylyl cyclase. The Journal of biological chemistry 7 32493772
2008 Two domains of RD3 antifreeze protein diffuse independently. Biochemistry 7 18459801
2022 Structural basis of retinal membrane guanylate cyclase regulation by GCAP1 and RD3. Frontiers in molecular neuroscience 6 36157073
2013 RD3: a challenge and a promise. JSM biotechnology & biomedical engineering 6 25679013
2020 Optical coherence tomography and fundus autofluorescence imaging in an infant with RD3-related leber congenital amaurosis. Ophthalmic genetics 3 32083505
2002 Pharmacokinetics of a benzodithiin (RD3-0028) following aerosol treatment in rat. Xenobiotica; the fate of foreign compounds in biological systems 3 11820507
2018 Chemical shift assignments of retinal degeneration 3 protein (RD3). Biomolecular NMR assignments 2 29327102
2025 Generation and validation of a Leber Congenital Amaurosis, Type 12 patient-specific iPSC line (LVPEIi006-B) with a splice-site mutation in RD3 and an isogenic mutation-corrected iPSC line (LVPEIi006-B-1). Stem cell research 1 40188639
2026 Cellular Identity Crisis: RD3 Loss Fuels Plasticity and Immune Silence in Progressive Neuroblastoma. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 0 41619263
2026 Structural and functional investigation of RD3-GCAP1 interaction in retinal photoreceptors under normal and disease conditions. International journal of biological macromolecules 0 41819313
2024 Generation of Leber congenital amaurosis, type 12 patient-specific induced pluripotent stem cell line (LVPEIi006-A), harboring a homozygous mutation in RD3. Stem cell research 0 38479331